Pneumonia Bibliography

Pneumonia Bibliography

IDSA guidelines

Mandell LA, Bartlett JG, Dowell SF, et al. Update of Practice Guidelines for the Management of Community Acquired Pneumonia in Immunocompetent Adults. CID. 2003;37:1405-33.

Guidelines

Battleman DS. Callahan M. Thaler HT. Rapid antibiotic delivery and appropriate antibiotic selection reduce length of hospital stay of patients with community-acquired pneumonia: link between quality of care and resource utilization. Arch Int Med. 2002;162:682-8.

Dean NC. Silver MP. Bateman KA. James B. Hadlock CJ. Hale D. Decreased mortality after implementation of a treatment guideline for community-acquired pneumonia. Am J Med. 2001;110:451-7.

Marrie TJ. Lau CY. Wheeler SL, et al. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. JAMA. 2000;283:749-55.

Meehan TP. Fine MJ. Krumholz HM, et al. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA. 1997;278:2080-4.

Ramirez JA. Vargas S. Ritter GW, et al. Early switch from intravenous to oral antibiotics and early hospital discharge: a prospective observational study of 200 consecutive patients with community-acquired pneumonia. Arch Int Med. 1999;159:2449-54.

Drug resistant pneumococci

Aspa J, Rajas O, Rodriguez de Castro F, et al. Drug-resistant pneumococcal pneumonia: clinical relevance and related factors. CID. 2004;38:787-98.

Doern GV, Brown SD. Antimicrobial susceptibility among community-acquired respiratory tract pathogens in the USA: data from PROTEKT US 2000–01. J Inf. 2004;48:56-65.

Ewig S, Ruiz M, Torres A, et al. Pneumonia acquired in the community through drug-resistant Streptococcus pneumonia. J Respir Crit Care Med. 1999;159:1835-42.

Lonks JR, Garau J, Gomez L, et al. Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae. CID. 2002;35:556-64.

Song J, Sook-in J, Ki HK, et al. Clinical outcomes of pneumococcal pneumonia caused by antibiotic resistant strains in asian countries: a study by the asian network for survelliance of resistant pathogens. CID. 2005;38:1570-8.

Yu VL, Chiou CC, Feldman C, et al. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. CID. 2003;37:230-7.

Monotherapy vs. Dual therapy

Gleason PP, Meehan TP, Fine JM, et al. Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch Int Med. 1999;159:2562-72.

Martinez FJ. Monotherapy versus dual therapy for community-acquired pneumonia in hospitalized patients. CID. 2004;38:S328-340.

Martinez J, Horcajada JP, Almela M, et al. Addition of a macrolide to a beta-lactam based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia. CID. 2003;36:389-95.

Stahl JE, Barza M, DesJardin J, et al. Effect of macrolides as part of initial empiric therapy on length of stay in patients hospitalized with community acquired pneumonia. Arch Int Med. 1999;159:2576-80.

Waterer GW, Somes GW, Wunderink RG. Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia. Arch Int Med. 2001;161:1837-42.

Fluoroquinolone resistance

Chen DK, McGeer A, de Azavedo JC, et al. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. NEJM. 1999;341:233-39.

Ketolides

Ackermann G, Rodloff AC. Drugs of the 21st century: telithromycin (HMR 3647)-the first ketolide. J Antimicr Chemo. 2003;51:497-511.

Clark JP, Langston E. Ketolides: a new class of antibacterial agents for treatment of community-acquired respiratory tract infections in a primary care setting. Mayo Clin Proc. 2003;78:1113-24.

Save the Quinolones!

File TM. Current challenges in the treatment of community-acquired pneumonia. CID. 2004;38:S1-4.

Short Course Antibiotic therapy

File TM. Clinical efficacy of newer agents in short-duration therapy for community-acquired pneumonia. CID. 2004;39:159-64.

Importance of Immunization

Nichol KL, Nordin J, Mullooly J, et al. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. NEJM. 348;14:1322-32.